0

COREG CR از شرکت WOODWARD

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COREG CR از شرکت WOODWARD

New Drug Application (NDA): 022012

Company: WOODWARD

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COREG CR CARVEDILOL PHOSPHATE 10MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes No
COREG CR CARVEDILOL PHOSPHATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes No
COREG CR CARVEDILOL PHOSPHATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes Yes
COREG CR CARVEDILOL PHOSPHATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/19/2008 ORIG-11 Approval

Type 2 – New Active Ingredient and Type 3 – New Dosage Form

STANDARD

Label is not available on this site.

10/20/2006 ORIG-1 Approval

Type 2 – New Active Ingredient and Type 3 – New Dosage Form

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022012lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/022012s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/022012s000TOC.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/14/2017 SUPPL-22 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022012Orig1s022ltr.pdf

10/02/2015 SUPPL-21 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022012s021lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022012Orig1s021ltr.pdf

07/06/2011 SUPPL-20 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020297s036,022012s020ltr.pdf

01/06/2011 SUPPL-19 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s017s019lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022012s017,s019ltr.pdf

01/06/2011 SUPPL-17 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s017s019lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022012s017,s019ltr.pdf

01/25/2011 SUPPL-16 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020297s033,022012s016ltr.pdf

06/23/2009 SUPPL-13 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022012s010s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022012s010,s013ltr.pdf

12/19/2008 SUPPL-11 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022012s011lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022012s011ltr.pdf

06/23/2009 SUPPL-10 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022012s010s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022012s010,s013ltr.pdf

10/19/2007 SUPPL-4 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s004lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022012s004ltr.pdf

08/03/2007 SUPPL-3 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022012s003ltr.pdf

07/16/2007 SUPPL-1 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022012s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/14/2017 SUPPL-22

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf
10/02/2015 SUPPL-21

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022012s021lbl.pdf
07/06/2011 SUPPL-20

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s020lbl.pdf
01/25/2011 SUPPL-16

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s016lbl.pdf
01/06/2011 SUPPL-19

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s017s019lbl.pdf
01/06/2011 SUPPL-17

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022012s017s019lbl.pdf
06/23/2009 SUPPL-13

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022012s010s013lbl.pdf
06/23/2009 SUPPL-10

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022012s010s013lbl.pdf
12/19/2008 SUPPL-11

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022012s011lbl.pdf
10/19/2007 SUPPL-4

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s004lbl.pdf
08/03/2007 SUPPL-3

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s003lbl.pdf
07/16/2007 SUPPL-1

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022012s001lbl.pdf
10/20/2006 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022012lbl.pdf

COREG CR

CAPSULE, EXTENDED RELEASE;ORAL; 10MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 10MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204717 IMPAX LABS INC
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 10MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090132 SUN PHARM INDUSTRIES
COREG CR CARVEDILOL PHOSPHATE 10MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 022012 WOODWARD

CAPSULE, EXTENDED RELEASE;ORAL; 20MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204717 IMPAX LABS INC
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090132 SUN PHARM INDUSTRIES
COREG CR CARVEDILOL PHOSPHATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 022012 WOODWARD

CAPSULE, EXTENDED RELEASE;ORAL; 40MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204717 IMPAX LABS INC
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090132 SUN PHARM INDUSTRIES
COREG CR CARVEDILOL PHOSPHATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 022012 WOODWARD

CAPSULE, EXTENDED RELEASE;ORAL; 80MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 204717 IMPAX LABS INC
CARVEDILOL PHOSPHATE CARVEDILOL PHOSPHATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 090132 SUN PHARM INDUSTRIES
COREG CR CARVEDILOL PHOSPHATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 022012 WOODWARD
بخوانید  CLOBAZAM از شرکت TARO
برچسب‌ها:

نظرات کاربران